HR 4832
107th Congress
House
Health
Clinical trials
Congress
Congressional reporting requirements
Cost effectiveness
Drugs
Electronic government information
Finance and Financial Sector
Government Operations and Politics
Government publicity
Internet
Medicaid
Medicare
Pharmaceutical research
Science, Technology, Communications
Social Welfare
Prescription Drug Comparative Effectiveness Act of 2002
Introduced: May 23, 2002
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 3, 2002
Referred to the Subcommittee on Health.
May 23, 2002
Referred to the House Committee on Energy and Commerce.
May 23, 2002
Introduced in House
Plain-English summary
Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2